<DOC>
	<DOCNO>NCT01293435</DOCNO>
	<brief_summary>This study collect real-life data patient community acquire pneumonia ( CAP ) OR complicate skin skin structure infection ( cSSSI ) ass burden disease , review treatment pathway , evaluate health resource use identify area unmet medical need . The aim study compare patient admit hospital CAP cSSSI manage across Europe . This do collecting data understand patient disease characteristic , current practice treatment , outcomes patient . Overall 4000 patient recruit 10 European country .</brief_summary>
	<brief_title>Study Evaluating Management Patients With Community-Acquired Pneumonia ( CAP ) Complicated Skin Infections</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<criteria>Patients hospitalise CAP cSSSI 1 . CAP : Radiographicallyconfirmed bacterial pneumonia AND Requiring treatment IV antimicrobial startup therapy 2. cSSSI : Affecting deep soft tissue and/or require significant surgical intervention develop abcess/ulcer/cellulitis low limb AND Having least two local sign one systemic sign cSSS AND Treatment antimicrobial Patients already participate clinical trial interventional study . 1 . CAP : CAP suitable outpatient therapy oral antimicrobial agent . 2. cSSSI : Uncomplicated SSSI . Skin skinstructure infection high cure rate surgical incision alone aggressive local skin care .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Community Acquired Pneumonia ( CAP )</keyword>
	<keyword>Complicated Skin Skin Structures Infections ( cSSSI )</keyword>
	<keyword>Complicated Skin Soft Tissues Infections ( cSSTI )</keyword>
	<keyword>Antibiotics</keyword>
	<keyword>Infection management</keyword>
	<keyword>Use Resources</keyword>
	<keyword>MRSA</keyword>
	<keyword>PRSP</keyword>
</DOC>